Raising full-year adjusted DEPS guidance to $22.15-$22.30
Roper reported solid Q2 results, beating EPS and revenue expectations, and raised full-year guidance for the second time. AI product momentum is accelerating with multiple agentic SKU launches across the portfolio, though customer adoption is still early. The company expects M&A activity to improve later this year and has over $5B of capacity for deployment. Q2 revenue $2.1B (+9% total, +5% organic), EPS $5.38 above guidance range.
Buzzberg readRaising full-year adjusted DEPS guidance to $22.15-$22.30Roper reported solid Q2 results, beating EPS and revenue expectations, and raised full-year guidance for the second time. AI product momentum is accelerating with multiple agentic SKU launches across the portfolio, though customer adoption is still early. The company expects M&A activity to improve later this year and has over $5B of capacity for deployment. Q2 revenue $2.1B (+9% total, +5% organic), EPS $5.38 above guidance range.Read full analysisCollapse analysis
Roper reported solid Q2 results, beating EPS and revenue expectations, and raised full-year guidance for the second time. AI product momentum is accelerating with multiple agentic SKU launches across the portfolio, though customer adoption is still early. The company expects M&A activity to improve later this year and has over $5B of capacity for deployment. Q2 revenue $2.1B (+9% total, +5% organic), EPS $5.38 above guidance range.
Full-year adjusted EPS raised to $22.15-$22.30; Q3 guided to $5.75-$5.80.
AI product cadence accelerated: six agentic SKUs at VertiFOR, new agents at Adderant, DAT, ProCare, and others.
Deltek showed stabilization but no GovCon trend call yet; DAT freight market improving; Neptune ahead of plan.
Revenue$2.1089B
+1% QoQ
EPS$5.38
+4% QoQ
Gross margin69.71%
reported
Op margin27.73%
reported
What changed this quarter
01
Guidance
Raising full-year adjusted DEPS guidance to $22.15-$22.30
Management stated AI momentum continues to build at an accelerating pace, with numerous agentic product releases across the portfolio, and that demand is strong but adoption pace is still developing as customers change workflows.
04
Other
Expect M&A activity to break loose later this year
AI product cadence accelerated: six agentic SKUs at VertiFOR, new agents at Adderant, DAT, ProCare, and others.
AI, capex & demand read
AI
Platform & monetization
Management stated AI momentum continues to build at an accelerating pace, with numerous agentic product releases across the portfolio, and that demand is strong but adoption pace is still developing as customers change workflows.
Demand
Bookings & conversion
Not ready to call a turn in GovCon market. Management expressed confidence in solid results, raised guidance, and highlighted accelerating AI momentum, though cautious on Deltek and AI adoption pace, leading to an upbeat but measured tone.
Tone · upbeat
Management expressed confidence in solid results, raised guidance, and highlighted accelerating AI momentum, though cautious on Deltek and AI adoption pace, leading to an upbeat but measured tone.
Ametek is acquiring the instrumentation businesses of Indicor, in which Roper holds a minority stake; the ~$1.4B gross proceeds will strengthen Roper's balance sheet for future M&A.
“Indicor announced an agreement to sell its instrumentation businesses to Ametek which is expected to close in the second half of this year.”
Jason ConleyExecutive Vice President and Chief Financial Officer
… and $2.9 billion drawn on our $3.5 billion revolver. As Neil mentioned, during the quarter we repurchased $3.6 million of shares for $1.2 billion at an average price of approximately $341 per share. That brings our cumulative repurchases to 9 million shares, spending $3.2 billion since this program began. Said differently, we have repurchased over 8% of our shares in eight months, which gets us back to our 2013 share count position. Also, Indicor announced an agreement to sell its instrumentation businesses to Ametek which is expected to close in the second half of this year. As a minority holder in Indicor, we expect gross proceeds of approximately $1.4 billion or an estimated $1.2 billion after tax, which further strengthens our balance sheet and deployment capacity. Of note, the flow control businesses remain in the Indicor portfolio and will provide additional liquidity following a competitive sale process, which is not yet factored into our capacity framework. With good visibility into forward free cash flow and the expected IndiCor instrumentation proceeds, we retain more than $5 billion of annualized capacity for capital deployment. We expect M&A activity to break loose …
🍪 Cookies
We use cookies to operate this site and for analytics. Declining won't affect your access to content.